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Btbd3 expression regulates compulsive-like and
exploratory behaviors in mice
Summer L. Thompson1,2, Amanda C. Welch1, Emily V. Ho1, João M. Bessa3,4, Carlos Portugal-Nunes3,4, Mónica Morais3,4,
Jared W. Young1, James A. Knowles5 and Stephanie C. Dulawa1
Abstract
BTB/POZ domain-containing 3 (BTBD3) was identified as a potential risk gene in the first genome-wide association
study of obsessive-compulsive disorder (OCD). BTBD3 is a putative transcription factor implicated in dendritic pruning
in developing primary sensory cortices. We assessed whether BTBD3 also regulates neural circuit formation within
limbic cortico-striato-thalamo-cortical circuits and behaviors related to OCD in mice. Behavioral phenotypes associated
with OCD that are measurable in animals include compulsive-like behaviors and reduced exploration. We tested Btbd3
wild-type, heterozygous, and knockout mice for compulsive-like behaviors including cage-mate barbering, excessive
wheel-running, repetitive locomotor patterns, and reduced goal-directed behavior in the probabilistic learning task
(PLT), and for exploratory behavior in the open field, digging, and marble-burying tests. Btbd3 heterozygous and
knockout mice showed excessive barbering, wheel-running, impaired goal-directed behavior in the PLT, and reduced
exploration. Further, chronic treatment with fluoxetine, but not desipramine, reduced barbering in Btbd3 wild-type and
heterozygous, but not knockout mice. In contrast, Btbd3 expression did not alter anxiety-like, depression-like, or
sensorimotor behaviors. We also quantified dendritic morphology within anterior cingulate cortex, mediodorsal
thalamus, and hippocampus, regions of high Btbd3 expression. Surprisingly, Btbd3 knockout mice only showed modest
increases in spine density in the anterior cingulate, while dendritic morphology was unaltered elsewhere. Finally, we
virally knocked down Btbd3 expression in whole, or just dorsal, hippocampus during neonatal development and
assessed behavior during adulthood. Whole, but not dorsal, hippocampal Btbd3 knockdown recapitulated Btbd3
knockout phenotypes. Our findings reveal that hippocampal Btbd3 expression selectively modulates compulsive-like
and exploratory behavior.
Introduction
Obsessive-compulsive disorder (OCD) is a psychiatric
disorder characterized by intrusive and unwanted
thoughts, images, or urges and/or compulsive behaviors1.
Although OCD is often comorbid with anxiety disorders2,
the fifth edition of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-5) reclassified OCD into a new
category of disorders in which compulsive behavior is the
core feature, consistent with recent hypotheses that
compulsivity may comprise a transdiagnostic psychiatric
trait3,4. Compulsive behaviors are defined as maladaptive
repetitive behaviors that are performed despite no longer
leading to a goal, and are typically inflexible in nature5–7.
Unlike obsessions, compulsive behavior can be oper-
ationalized in rodent models. For one, chronic treatment
with serotonin reuptake inhibitors (SRIs), but not other
classes of antidepressants including norepinephrine
reuptake inhibitors (NRIs), provide effective treatment for
OCD8, and reduce compulsive-like behaviors in rodents
including route stereotypy, repetitive jumping, and flip-
ping9–12. Furthermore, aspects of compulsive behavior
can be measured directly in rodents, such as
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neuropsychological endophenotypes in cognitive tasks.
Our knowledge of the neurobiological underpinnings of
compulsive behavior remain incomplete, and animal
models provide an important tool for revealing these
mechanisms.
The first genome-wide association study (GWAS) of
OCD identified rs6131295, a single nucleotide poly-
morphism (SNP) located near BTB/POZ domain-
containing 3 (BTBD3), as genome-wide significant in the
trio, but not the case-control, portion of the study13. This
SNP was also an expression quantitative trait locus
(eQTL) for BTBD313, but was not significant in a second
GWAS14 or a meta-analysis15. However, these GWASs
were perhaps insufficiently powered to identify genome-
wide significant loci. The function of BTBD3 has been
largely unknown, until a recent report identified a role for
BTBD3 in neurodevelopment. BTBD3 was found to orient
dendrites toward active axon terminals and regulate
activity-dependent dendritic pruning in primary sensory
cortex during neonatal development, thus facilitating
neural circuit formation16. Yet, whether BTBD3 also
performs this function in other brain regions in which it is
highly expressed, including limbic cortico-striato-
thalamo-cortical (CSTC) circuits, remains unknown.
In humans and rodents, BTBD3 is highly expressed
within limbic CSTC circuitry including the mediodorsal
thalamus, anterior cingulate cortex (ACC), and hippo-
campus17,18. Within this circuit, BTBD3 expression
increases rapidly during early postnatal development and
peaks during childhood and adolescence in humans18 and
mice16,17. Dysfunction within limbic CSTC circuitry is
associated with abnormal repetitive behaviors19,20, and
specifically with compulsive behaviors21,22. Furthermore,
the hippocampus, mediodorsal thalamus, and ACC are
key structures for goal-directed decision-making23–27,
which is impaired in OCD28–30, and theorized to underlie
expression of compulsive behaviors31,32. Thus, we aimed
to determine the role of BTBD3 in the morphological
development of this circuit, and in the expression of
compulsive-like behaviors.
Herein, we sought to address three key questions: (i)
Does Btbd3 expression modulate behaviors related to
OCD, such as compulsive-like behaviors? (ii) Does alter-
ing Btbd3 expression affect neuronal morphology within
the ACC, mediodorsal thalamus, or hippocampus? (iii) In
which region of the limbic CSTC circuit does Btbd3
expression regulate behavioral phenotypes observed? To
address these questions, we used Btbd3 wild-type (WT),
heterozygous (HT), and knockout (KO) mice to assess
behavioral phenotypes and dendritic morphology within
the mediodorsal thalamus, ACC, CA1, and dentate gyrus.
Finally, we generated and used Btbd3flox mice and an
adeno-associated virus (AAV) expressing Cre recombi-
nase (Cre) to knockdown (KD) either dorsal or whole
hippocampal Btbd3 expression during the early neonatal
period, and assessed behavioral consequences during
adulthood.
Materials and methods
Animals
Adult (minimum 7 weeks) male and female mice were
group-housed by sex on a 12:12 h light:dark cycle (~500 lx
overhead lighting in housing room) with ad libitum
standard chow and water except during cognitive testing
(see below). All testing occurred during the light cycle
unless otherwise specified. Btbd3 KO mice were on a 129/
B6 background (RIKEN, Saitama, Japan). Experimental
cohorts were bred in-house and generated from litter-
mates from heterozygous (HT) Btbd3 crosses, resulting in
variable group sizes based on breeding production.
Minimum sample sizes were targeted based on previous
experience with these paradigms. Large cohort sizes were
used for assessing barbering, based on previous reports of
low barbering frequency in control animals33. Btbd3-
floxed (Btbd3flox) mice were generated on a pure C57BL/
6J background (Transviragen, Research Triangle Park,
NC) using CRISPR/Cas9 to insert loxP sites flanking exon
2 of Btbd3. Mice weighed 16–35 g. Genotype or viral
condition, sex, and home cage were counterbalanced
across testing. Sample sizes for each test are listed in the
figure legends. All procedures were performed in accor-
dance with the local Institutional Animal Care and Use
Committee and the National Institutes of Health Guide-
lines for the Care and Use of Laboratory Animals.
Drugs
Drugs were administered in the drinking water in
opaque bottles for 14 weeks. The SRI fluoxetine was
administered at 80 mg/L to achieve a 10 mg/kg/day dose
and changed weekly. The NRI desipramine was adminis-
tered at 215mg/L to achieve a 20mg/kg/day dose and
changed biweekly34,35. Fluoxetine and desipramine were
used because chronic treatment with SRIs, but not other
classes of antidepressants, serve as effective monotherapy
for OCD36,37.
Behavioral studies
Barbering
Mice were pair-housed by sex and genotype, photo-
graphed weekly, and inspected for evidence of barbering,
an abnormal behavior in which animals repetitively clip or
pluck the fur of their cage mates, generating bald spots38.
See Supplementary Information.
Cognitive testing
Male mice were food-restricted to 85% of free-feeding
bodyweight to motivate responses for food reward,
trained to respond on a fixed-ratio 1 (FR1) schedule, and
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then assessed in a Go/No-Go task to measure response
inhibition39, progressive ratio breakpoint (PRBP) task to
measure motivation for reward40, and finally the prob-
abilistic learning task (PLT) to measure goal-directed and
habitual decision-making strategies41. See Supplementary
Information.
Wheel-running
In order to track home-cage locomotor activity, mice
were singly housed in standard cages equipped with
wireless running wheels (Med Associates, St. Albans,
VT). Wheel revolution counts were continuously
transmitted to a computer running Wheel Manager
Software (Med Associates) for 7 days in the mouse
housing room. Mice that never acclimated to running
wheels (such as burying the wheel in bedding; quantified
as fewer than 300 total wheel revolutions for the entire
week) were excluded (n= 6).
Open field
In order to track locomotor activity in a novel envir-
onment, mice were placed in a corner of an open field
(OF) apparatus (Accuscan, Columbus, OH) equipped with
a central overhead light (~100 lx) and activity was mon-
itored for 45 min in 5-min bins. Versamax software
(Accuscan, Columbus, OH) generated primary outcome
measures including distance traveled (locomotion), ver-
tical rearing (exploration), and center activity (anxiety).
The spatial scaling exponent d (spatial d) was calculated
using NightOwl software (Custom) and Python (Python
Software Foundation, Beaverton, OR). Spatial d describes
the smoothness of the path of the animal, where high
values indicate many directional changes, whereas low
values indicate a more straight and rigid path, char-
acteristic of compulsive circling in the OF10,11,42.
Dig test
To measure exploration43, mice were placed in novel,
clean standard cages with fresh bedding (1″ deep) and
recorded for 3 min35. Videos were scored by a blind
observer for digging behavior, defined by significant dis-
placement of bedding using forelimbs.
Marble-burying
Marble burying was assessed as an additional measure
of exploratory digging44–47. Fresh cages were filled with
5 cm bedding with 12 marbles placed on top in a 3 × 4
grid with 4 cm center-to-center spacing. Number of
marbles buried to 2/3 depth was recorded after 30 min44.
Nest-building
Nest-building is a measure of well-being in mice48. Mice
were given a pre-weighed compressed cotton nestlet
(Ancare, Bellmore, NY) while singly housed in the home
cage49. In the 8-h version, nestlets were removed 8 h later
and any unused nestlet was weighed. In the overnight
version, nestlets were provided just before initiation of the
dark cycle. Fourteen hours later, any unused nestlet was
weighed.
Light-dark test
The light-dark test was performed to assess anxiety-like
behavior50. The light-dark test was performed in the OF
(overhead light adjusted to ~40 lx) using dark inserts to
cover half the chamber (Omnitech Electronics, Inc.,
Columbus, OH, USA). Animals began in the dark side of
the chamber and activity was recorded for 10min. Out-
come measures were duration on each side, proportion of
distance traveled in the dark, and latency to enter the
light side.
Novelty-induced hypophagia (NIH)
NIH testing assesses anxiety, and was performed as
previously described51. Briefly, mice underwent three days
of training to consume sweetened condensed milk. The
following day, mice were presented with sweetened con-
densed milk in the home cage for 30min. Latency to drink
and consumption volume were measured. The following
day, mice were presented with sweetened condensed milk
in a novel cage with no bedding and bright lighting for
30min. Latency to drink and consumption volume were
recorded.
Forced swim test (FST)
Animals were tested in the FST to assess depression-like
behavior52. Mice were placed in opaque plastic buckets
(18 cm × 20.5 cm) filled with 23–25 oC water for 6 min.
The day prior to testing, animals underwent a 15 min
pretest under the same conditions. Each session was
recorded. The video from the test day was hand-scored by
a blind observer for time spent immobile, swimming, or
climbing in the final 4 min.
Viral-mediated Btbd3 knockdown
In order to assess the role of hippocampal Btbd3
expression in behavior, postnatal day 2 Btbd3flox mouse
pups received intracranial infusions of AAV expressing
Cre: AAV2/8-CMV-Cre-P2A-tdTomato-WPRE (AAV-
Cre; Viral Vector Core Facility, University of Iowa, Iowa
City, IA) or control: AAV2/8-CMV-tdTomato-WPRE
(AAV-tdTomato), targeting the whole hippocampus
(0.3 mm anterior, 2.0 mm lateral, 2.5 mm ventral of
lambda), or only the dorsal half of the hippocampus
(1.0 mm anterior, 0.3 mm lateral, 2.7 mm ventral of
lambda). See Supplementary Information. Mice were
assessed for behavior during adulthood (8–13 weeks) in a
subset of paradigms tested in the global Btbd3 KO mice.
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Statistical analysis
Dependent measures were analyzed using repeated
measures or factorial analysis of variance (ANOVA).
Significant interactions were resolved by assessing simple
main effects for factors with more than two groups with
Bonferroni correction. Post hoc tests for between-subjects
factors were performed using Student–Newman–Keuls.
Where appropriate, Kruskal–Wallis one-way ANOVAs
were performed, and Mann–Whitney U tests with Bon-
ferroni correction were used as post hoc tests. Categorical
dependent measures were analyzed using chi-square tests
for endpoint factors which were confirmed with a boot-
strap analysis, and Kaplan–Meier survival curves with
Mantel–Cox logrank tests for repeated measures analyses.
Alpha was set at 0.05. A few mice were excluded from
analyses because of experimental errors, but no statistical
outliers were removed.
Results
Btbd3 KO mice exhibit compulsive-like behavior
We observed a high frequency of cage-mate barbering
in Btbd3 KO colony home cages (Fig. 1a); therefore, we
monitored barbering behavior by pair-housing mice of
identical sex and genotype. Chi-square analysis
revealed that barbering was unevenly distributed across
the three genotypes (Fig. 1b; Χ2(2, n=647)= 11.38; p <
0.005). Btbd3 HT (Χ2(1, n=486)= 7.73; p < 0.01) and KO
(Χ2(1, n=332)= 11.77; p < 0.0001) groups each had an
increased incidence of barbering compared to WT. A
bootstrap analysis (100,000 iterations) confirmed that
all of the chi-square statistics above were unlikely (p’s
< 0.05) to be due to the uneven group numbers that
resulted from heterozygous breeding in this observa-
tional cohort. Bald patches in the fur were observed
primarily on the dorsal surface of the body and the face,
characteristic of barbering by cage mates, rather than
self-barbering33.
We then assessed the effects of OCD-effective (SRI
fluoxetine) or OCD-ineffective antidepressant treatment
(NRI desipramine) on barbering36,37 for 14 weeks to
determine whether barbering may be a compulsive-like
phenotype. Pooled across genotypes, log-rank tests
revealed that fluoxetine reduced the onset of barbering
relative to vehicle starting at 4 weeks of treatment (Fig.
1c), and throughout the remainder of treatment, except
for weeks 7 and 8 (Supplementary Information). In
contrast, desipramine did not affect onset of barbering
(Χ2(1, n=177)= 2.09; p= 0.15). Furthermore, within
fluoxetine-treated animals, a genotype effect was iden-
tified (X2(2, n=95)= 16.75; p < 0.0005). Therefore, the
effect of fluoxetine on barbering within each genotype
was examined. Within Btbd3 WT mice, fluoxetine pre-
vented barbering onset (Fig. 1d), and this effect was
significant by 6 weeks of treatment (Χ2(1, n=56)= 4.59;
p < 0.05). Within Btbd3 HT mice, fluoxetine became
effective at 12 weeks of treatment (Fig. 1e; Χ2(1, n=64)=
4.50; p < 0.05) and remained significant through week 14
(Χ2(1, n=64)= 4.50; p < 0.05). In contrast, fluoxetine never
affected Btbd3 KO barbering incidence (Fig. 1f; week 14:
Χ2(1, n=65)= 0.40; p= 0.53). These effects were not due
to genotypic differences in fluoxetine metabolism (Sup-
plementary Information).
Next, we tested cognitive domains relevant to compul-
sive disorders using operant conditioning. ANOVAs
revealed that there was no effect of genotype on FR1
training (F(2,49)= 0.27; p= 0.76) or on false alarm rate in
the Go/No-Go task (Supplementary Information), which
measures response inhibition39,53. In the PLT, which
measures reinforcement learning and response strate-
gies41, no effects of genotype were identified for Block 1
(reward probabilities of 90%/10%) or Block 2 (reward
probabilities of 80%/20%; data not shown). However, in
Block 3 (reward probabilities of 70%/30%), Btbd3 KO
mice were less accurate than WT or HT mice (Fig. 1g;
F(2,35)= 8.01; p < 0.005). An ANOVA and post hoc tests
revealed a higher proportion of target lose-shift responses
in Btbd3 KO mice versus WT mice (F(2,35)= 4.96; p <
0.05; Fig. 1h). Furthermore, Btbd3 KO mice more fre-
quently reselected the non-target port after being rewar-
ded than WT mice (Fig. 1i; F(2,23)= 4.24; p < 0.05).
Genotype did not affect target win-stay or non-target
lose-shift patterns (Supplementary Fig. 1d, e). Lastly, mice
were assessed in the PRBP test for any potentially con-
founding effects of genotype on motivation in the PLT,
but genotype did not affect breakpoint (Fig. 1j; F(2,43)=
1.58; p= 0.22).
Next, wheel-running was assessed, which is excessive in
some rodent models of compulsive behavior54. A three-
way interaction of day, cycle, and genotype was identified
by a repeated measures ANOVA for wheel revolutions
(F(12,312)= 2.32; p < 0.01). Post hoc ANOVAs and then
post hoc tests revealed that Btbd3 KO mice accrued more
wheel revolutions than WT or HT mice during the dark
cycle (Fig. 1k; F(2,55)= 4.57; p < 0.05), but not the light
cycle (F(2,55)= 0.35; p= 0.70; data not shown).
Btbd3 KO mice show reduced exploration
We next assessed exploration in Btbd3 mice, as novelty-
seeking is reduced in OCD55–58. In the OF test, a genotype
by bin interaction (F(16,1040)= 2.57; p < 0.0001) in a repe-
ated measures ANOVA and post hoc tests revealed that
Btbd3 KO mice traveled a greater total distance than WT
or HT mice in bins 1–4 (Fig. 2a). All genotypes exhibited
locomotor habituation (Supplementary Information).
Btbd3 HT and KO mice had reduced instances of vertical
rearing relative to WT mice (Fig. 2b; F(2,130)= 6.97; p <
0.005) and spent less time rearing than WT mice (Fig. 2c;
F(2,130)= 7.18; p < 0.005).
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Btbd3 mice were then assessed for exploratory digging.
The distribution of the data violated the normality
assumption for using parametric tests even after attempts
at transforming the data, so nonparametric statistics were
used. A Kruskal–Wallis one-way ANOVA found a main
effect of genotype on latency to dig (H(2)= 6.43; p < 0.05),
with Btbd3 KO mice showing a longer latency to dig than
WT mice (Fig. 2d; U= 289; p < 0.025). Furthermore,
Btbd3 KO mice spent less time digging than WTs (Fig. 2e;
H(2)= 5.93; p < 0.05; U= 286; p < 0.025). Lastly, genotype
altered bout duration (H(2)= 8.20; p < 0.05), with Btbd3
KO mice performing briefer digging bouts than WT mice
(Fig. 2f; U= 265; p < 0.025). No effect of genotype was
identified for number of digging bouts (Fig. 2g; H(2)=
4.36; p= 0.11).
Btbd3 mice were tested in the marble-burying paradigm
to confirm genotype effects on digging behavior44–47. An
ANOVA and post hoc tests revealed that Btbd3 KO mice
buried fewer marbles than WT or HT mice (Fig. 2h;
F(2,66)= 5.56; p < 0.01).
Fig. 1 Btbd3 knockout induces compulsive-like behavior. a Representative example photographs of dorsal surface of the coat in BTBD3 WT (left),
HT (middle), and KO (right) mice. b Increased incidence of barbering behavior was identified in Btbd3 HT and KO mice in a chi-square analysis (n= 81
female/90 male WT, 150 female/165 male HT, 83 female/78 male KO mice). Across genotypes c, chronic fluoxetine reduced onset of barbering over
time in a cohort of initially 100% non-barbers, whereas desipramine did not significantly alter barbering behavior at any time point in a Kaplan–Meier
survival curve analysis (n= 15 female/13 male WT, 16 female/15 male HT, and 19 female/12 male KO for vehicle treatment, 19 female/13 male WT, 13
female/12 male HT, and 14 female/16 male KO for desipramine treatment, and 14 female/14 male WT, 16 female/17 male HT, and 19 female/15 male
KO mice in the fluoxetine treatment group). Drops indicate time points when mice began to barber a cage mate, with the cumulative fraction of
non-barbers indicated on the Y-axis. Within Btbd3 WT mice d, fluoxetine completely prevented onset of barbering behavior. Within Btbd3 HT mice e,
fluoxetine-reduced barbering behavior. Within Btbd3 KO mice f, barbering was unaffected by fluoxetine treatment. g Btbd3 KO mice showed reduced
accuracy on the PLT (n= 13 WT, 16 HT, 17 KO mice, all male), which was driven by an increased frequency of lose-shift responses on the target port h
and an increased frequency of win-stay responses on the non-target port i. j Breakpoint was unaffected by Btbd3 genotype in the PRBP task in an
ANOVA. k Btbd3 KO mice exhibited excessive wheel-running behavior during the dark cycle (n= 10 WT, 9 HT, and 10 KO mice of each sex). Results
are expressed as mean values ± SEM, except for panels depicting categorical data, which does not have error. *p < .05 vs. WT or vehicle groups in a
chi-square analysis b, log-rank analysis c–f, or an ANOVA with post hoc tests g–k. WT wild-type, HT heterozygous, KO knockout, PLT probabilistic
learning task, PRBP progressive ratio breakpoint task
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Nest-building is considered a measure of well-being in
mice48, and nest-building deficits have been found in
numerous neuropsychiatric disorder models59–62. In the
nest-building task, a main effect of genotype was identi-
fied for original nestlet percentage remaining intact in an
ANOVA (F(2,65)= 4.33; p < 0.05), with post hoc tests
showing that Btbd3 KO mice left more nestlet untouched
than WT mice (Fig. 2i).
Btbd3 does not modulate anxiety-like or depression-like
behaviors or basic sensory and motor functioning
Anxiety and depression are often comorbid with
OCD2,63. Thus, Btbd3 mice were assessed for anxiety-like
and depression-like behaviors. In the light-dark test, no
effects of genotype were identified for either duration on
the light versus the dark side of the chamber (Fig. 3a) or
percent distance traveled in the dark side (Fig. 3b). An
ANOVA revealed a main effect of side of the chamber for
duration (F(1,84)= 140.97; p < 0.0001), indicating that
animals spent more time on the dark side. In the OF test,
no effect of genotype was identified for proportion of
distance traveled in the center (Fig. 3c) or time spent in
the center (Fig. 3d). Mice were assessed in the NIH test as
an additional measure of anxiety-like behavior. Since
latency data are often skewed, we examined the dis-
tribution of the data, and as a result log-transformed
latency to drink for statistical analysis. Neither a main
effect of genotype nor an interaction between genotype
and cage condition was identified for latency to drink
(Fig. 3e). A main effect of cage condition on latency to
drink was identified (F(1,49)= 152.30; p < 0.0001), indicat-
ing a longer latency to consume the sweetened condensed
milk in the novel cage. No effects of genotype were found
for total consumption (Fig. 3f). A main effect of cage
Fig. 2 Btbd3 knockout reduces exploration. a Btbd3 KO mice
traveled a greater total distance in the OF (n= 17 female/27 male WT,
34 female/27 male HT, and 11 female/20 male KO mice) than HT or
WT mice overall (left panel), which was confined to the first 20 min of
testing as revealed by the 5-min bin analysis (right panel). b Btbd3 HT
and KO mice showed fewer instances of vertical rearing and c spent
less time rearing across the session than WT mice in the OF. d–g In
the dig test (n= 13 female/14 male WT, 15 female/16 male HT, 20
female/13 male KO mice), Btbd3 KO mice had a greater latency to
initiate digging behavior d, reduced total time spent digging e, and
dug in briefer bouts than controls f. The number of dig bouts in the
dig test was unaffected by Btbd3 genotype g. h Btbd3 KO mice buried
fewer marbles (n= 14 female/12 male WT, 12 female/12 male HT, 9
female/13 male KO mice) than WT mice in the marble-burying test. i
Btbd3 KO mice left a greater portion of the nestlet intact than WT mice
in the 8-h nest-building paradigm (n= 12/genotype/sex). Results are
expressed as mean values ± SEM. *p < 0.05 vs. WT group in ANOVAs
resolved with post hoc tests. WT wild-type, HT heterozygous, KO
knockout, OF open field
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condition was identified for total consumption (F(1,51)=
102.50; p < 0.0001), indicating reduced consumption of
sweetened condensed milk in the novel versus the home
cage.
Btbd3 mice were assessed in the FST to evaluate
depression-like behavior. No effect of genotype was
identified for time spent immobile (Fig. 3g), swimming
(Fig. 3h), or climbing (Fig. 3i).
Finally, basic sensorimotor functioning was assessed in
Btbd3 mice to screen for potentially confounding effects
on compulsive-like and exploratory behaviors. No effects
of genotype were found in auditory, olfactory, somato-
sensory, or motor function (Supplementary Fig. 1f, g; 2).
See Supplementary Information.
Effects of Btbd3 expression on limbic CSTC dendritic
morphology
Dendritic morphology was assessed in limbic CSTC
brain regions with dense Btbd3 expression because
BTBD3 was previously reported to play a role in dendritic
morphology16. No effects of genotype were identified for
dendritic branching or spine density in the CA1 or den-
tate gyrus subregions of hippocampus, or in the medio-
dorsal thalamus. However, increased spine density in
Btbd3 KO mice was identified in the ACC (Supplemen-
tary Fig. 3). See Supplementary Information.
Whole hippocampal Btbd3 KD induces compulsive-like
behavior and decreases exploration
Due to robust Btbd3 expression in hippocampus17 and
the role of hippocampus in several behavioral phenotypes
for which deficits were identified in Btbd3 KOmice45,64, we
assessed the effects of neonatal, whole hippocampal Btbd3
KD on behavior during adulthood. We confirmed KD of
Btbd3 RNA (Fig. 4a, top left panel; F(1,7)= 46.39; p <
0.0005) and protein (Fig. 4a, top right panel; F(1,4)= 22.10;
p < 0.01) in the hippocampus of Btbd3flox mice receiving
viral infusion of AAV-Cre versus AAV-tdTomato. Btbd3
Fig. 3 BTBD3 does not affect anxiety-like or depression-like
behavior. Btbd3 genotype had no effect on proportion of time spent
a or distance traveled b in the dark side of the light-dark box (n= 15/
genotype/sex), proportion of distance traveled c or time spent in the
center d of the OF (n= 17 female/27 male WT, 34 female/27 male HT,
and 11 female/20 male KO mice), total latency to drink e, or total
consumption f of sweetened condensed milk in the NIH (n= 10 each
female/male WT, 10 female/9 male HT, 9 each female/male KO mice),
time spent immobile g, swimming h, or climbing i in the FST (n= 10/
genotype/sex, except female WT n= 9). Results are expressed as
mean values ± SEM. *p < 0.05 between conditions (dark versus light;
home versus novel cage) as determined by ANOVAs. OF open field,
NIH novelty-induced hypophagia, FST forced swim test
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KD did not alter wheel-running (Fig. 4c), but increased
locomotor activity (Fig. 4d; F(1,70)= 48.85; p < 0.0001) and
reduced locomotor habituation in the OF (Supplementary
Information). Btbd3 KD mice had reduced instances of
rearing within the first 5 min (Fig. 4e; F(8,560)= 3.93; p <
0.0005). For time spent rearing (Fig. 4f), an interaction
between viral condition and bin (F(8,560)= 3.49; p < 0.001)
and post hoc tests revealed that Btbd3 KD mice spent less
time rearing than control mice in time bins 1, 2, 4, and 5.
Btbd3 KD mice exhibited reductions in spatial d within
Fig. 4 (See legend on next page.)
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each time bin (Fig. 4g), except bins 4 and 6 (Fig. 4h, i;
F(8,504)= 2.32; p < 0.05).
Btbd3 KD mice buried fewer marbles than control mice
in the marble-burying test (Fig. 4j; F(1,70)= 10.87; p <
0.005) and used less nestlet than control mice in the nest-
building test (F(1,70)= 6.47; p < 0.05) as determined by an
ANOVA followed by post hoc tests (Fig. 4k).
Dorsal hippocampal Btbd3 KD does not mimic the Btbd3
KO phenotype
Next, we investigated whether Btbd3 KD in dorsal
hippocampus, which was recently implicated in goal-
directed planning26, would be sufficient to induce the
Btbd3 behavioral profile. No effect of Btbd3 KD was
identified on wheel-running (Fig. 5b), distance traveled
(Fig. 5c), instances or time spent rearing (Fig. 5d, e),
spatial d (Fig. 5f), or marble-burying (Fig. 5g; F(1,25)= 1.85;
p= 0.19) in ANOVAs. The only effect of neonatal Btbd3
KD in dorsal hippocampus was impaired nest-building in
the nest-building test (Fig. 5h; F(1,25)= 4.58; p < 0.05).
Discussion
Our results show that BTBD3 regulates compulsive-like
and exploratory behaviors across multiple paradigms in
mice. Btbd3 HT and KO mice exhibited increased bar-
bering, which was reduced by effective (SRI), but not
ineffective (NRI), OCD treatment. Additionally, Btbd3 KO
mice exhibited excessive wheel-running and poor goal-
directed decision-making, a trait that is thought to
underlie compulsive behavior. Btbd3 HT and KO mice
were less exploratory in the OF, dig, and marble-burying
tests. Furthermore, whole hippocampal, but not dorsal,
neonatal Btbd3 KD increased compulsive-like behaviors
and reduced exploration during adulthood, largely
mimicking the phenotype of constitutive Btbd3 KO mice.
Surprisingly, Btbd3 knockout spared dendritic morphol-
ogy within hippocampal subregions, but increased spine
density in ACC layer II/III pyramidal neurons, suggesting
that an alternative function of Btbd3 may mediate the
hippocampus-dependent behavioral effects observed. Our
findings indicate that reduced hippocampal Btbd3
expression leads to the development of compulsive-like
behaviors and reductions in exploration.
Btbd3 HT and KO mice exhibited compulsive-like
behaviors indicated by increased barbering, wheel-run-
ning, and impaired goal-directed behavior. Barbering is an
abnormal behavior observed only in confined animals38,
and is considered a repetitive, compulsive-like beha-
vior33,54,65. The idea that barbering is a compulsive-like
behavior is reinforced by our finding that chronic SRI, but
not NRI, treatment reduced barbering, paralleling treat-
ment response in OCD8. Interestingly, our finding that
barbering incidence was reduced by chronic fluoxetine
treatment in Btbd3 WT and HT, but not KO mice sug-
gests that Btbd3 expression may be required for these
anti-compulsive effects of fluoxetine. Increased barbering
has previously been reported in other genetically altered
mouse lines exhibiting a compulsive-like phenotype66,
and has been associated with deficits in extradimensional
shifting65, which measures cognitive flexibility7 and is
deficient in OCD67–69. While excessive wheel-running has
also been proposed as compulsive-like in rodent food
restriction-induced hyperactivity models based on the
pharmacological response profile70,71, effects across stu-
dies are not fully consistent with OCD72. Thus, the rela-
tionship between excessive wheel-running and
compulsivity appears somewhat unclear73. Alternatively,
other mouse lines exhibiting a compulsive-like phenotype
have also reported increased barbering and excessive
wheel-running54, suggesting that these phenotypes may
be linked. In addition to increased barbering and wheel-
running, Btbd3 KO mice also exhibited impaired
decision-making in the PLT, which assesses the balance of
goal-directed versus habitual decision-making strategies
during reinforcement learning41,74. Compulsive behavior
has been associated with alterations in this balance, with a
(see figure on previous page)
Fig. 4 Neonatal Btbd3 knockdown in whole hippocampus recapitulates the Btbd3 knockout phenotype. Cre virus successfully knocked down
RNA (a, top left) and protein (a, top right; bottom) in hippocampus in a qPCR assay (n= 7 AAV-tdTomato, 2 AAV-Cre virus) and a western blot (n= 3/
virus) relative to CTRL, respectively. The western blot image (a, bottom) shows samples from CTRL virus-infused mice in lanes 1, 3, and 5, and samples
from Btbd3 KD mice in lanes 2, 4, and 6. The dotted line indicates that the image was interrupted between these lanes in order to remove space
between the lanes, but the left and right-hand sides are from the same image of the blot. b Representative example of viral reporter tdTomato
expression in hippocampus. c Hippocampal Btbd3 KD did not affect number of wheel revolutions in the voluntary home cage wheel-running
assessment (n= 19 female/25 male AAV-tdTomato and 15 female/12 male AAV-Cre infused mice). d Hippocampal Btbd3 KD increased distance
traveled in the OF throughout testing (n= 19 female/26 male AAV-tdTomato and 16 female/13 male AAV-Cre infused mice). e Hippocampal Btbd3
KD reduced instances of vertical rearing only within the first 5-min bin. f Hippocampal Btbd3 KD reduced time spent rearing in the first half of testing.
g Hippocampal Btbd3 KD reduced spatial d throughout testing (example traces in h, i). Hippocampal Btbd3 KD mice buried fewer marbles in the
marble-burying paradigm (n= 19 female/26 male AAV-tdTomato and 16 female/13 male AAV-Cre infused mice) j and left more nestlet unused in the
overnight nest-building test k than CTRL mice (n= 19 female/26 male AAV-tdTomato and 16 female/13 male AAV-Cre infused mice). Results are
expressed as mean values ± SEM. *p < 0.05 vs. CTRL group in ANOVAs resolved with post hoc tests. KD knockdown, CTRL control virus: AAV-tdTomato,
OF open field, AAV adeno-associated virus, qPCR quantitative polymerase chain reaction, Cre AAV-Cre virus
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shift toward more habitual, and less goal-directed ten-
dencies3,4, as observed in OCD patients28–30. Thus, goal-
directed learning impairments are thought to contribute
to the development of compulsivity31,32. Therefore, the
reduction in goal-directed decision-making we observed
in Btbd3 KO mice is consistent with the increases in
barbering and wheel-running we also observed in these
mice. That Btbd3 KO mice exhibit multiple different
compulsive-like phenotypes is consistent with evidence
that discrete types of repetitive behaviors are interrelated
and subserved by partially overlapping CSTC circuitry19.
Btbd3 HT and KO mice also exhibited reduced
exploratory drive. Robust reductions in vertical rearing
were found in Btbd3 HT and KO mice. Btbd3 KO mice
also showed reduced digging43 and marble-burying. While
increased marble-burying has been widely used as a
measure of anxiety-like or compulsive-like behavior, this
behavior is reduced by many compounds that are inef-
fective treatments for anxiety or compulsivity73,75,
including acute treatment with SRIs76. Furthermore,
several rodent models of abnormal repetitive behavior
exhibit reductions in marble-burying, concomitant with
reduced digging or vertical rearing behavior77–79. Thus,
marble-burying has also been suggested to measure
exploration44–46. Interestingly, exploration is an integral
component of goal-directed behavior80, suggesting that
these two impairments in Btbd3 KO mice might be
related. Moreover, novelty-seeking, a trait that drives
exploration, is reduced in patients with OCD55–58. Lastly,
Btbd3 KO mice also showed impaired nest-building,
which has been associated with reduced well-being48.
Interestingly, anxiety-like and depression-like behaviors
were unaltered in Btbd3 HT and KO mice. Anxiety-like
behavior was unaffected in the light-dark, OF, and NIH
tests, well-established anxiety measures in rodents. These
results strongly suggest that reduced exploration in Btbd3
HT and KO mice does not reflect augmented anxiety,
consistent with previous reports that exploration and
Fig. 5 Neonatal Btbd3 knockdown in dorsal hippocampus does
not recapitulate the Btbd3 knockout phenotype. a Example of viral
reporter tdTomato expression in dorsal hippocampus. b Dorsal
hippocampal Btbd3 KD did not affect number of revolutions in wheel-
running (n= 5 female/4 male AAV-tdTomato, 9 female/9 male AAV-
Cre mice), c distance traveled in the OF (n= 5 female/4 male AAV-
tdTomato, 11 female/9 male AAV-Cre mice), vertical rearing in the OF
d, e, spatial d in the OF f, or g marble-burying (n= 5 female/4 male
AAV-tdTomato, 11 female/9 male AAV-Cre mice). h Neonatal dorsal
hippocampal Btbd3 KD mice left more nestlet unused than CTRL mice
in the nest-building paradigm (n= 5 female/4 male AAV-tdTomato, 11
female/9 male AAV-Cre mice). Results are expressed as mean values ±
SEM. *p < 0.05 vs. CTRL group in ANOVAs resolved with post hoc tests.
KD knockdown, CTRL control virus: AAV-tdTomato
Thompson et al. Translational Psychiatry           (2019) 9:222 Page 10 of 14
anxiety-like behavior are dissociable81. Furthermore,
depression-like behavior was unaffected by genotype in
the FST. Thus, our findings suggest that the behavioral
phenotypes observed in Btbd3 KO mice are not modu-
lated by anxiety-like or depression-like states. While
anxiety and depression are highly comorbid with OCD2,63,
anxiety and affective disorders are distinct from OCD. For
example, traits characteristic of OCD, eating disorders,
and addiction correlate with goal-directed behavior defi-
cits in humans, whereas anxiety and depression do not3,
suggesting distinct neuropsychological endophenotypes
between these classes of disorders. Moreover, SRIs and
NRIs serve as effective treatment for anxiety and depres-
sion82–85, whereas only SRIs provide effective mono-
therapy in OCD8, a treatment profile that parallels our
barbering results. This distinction is further reflected in
the DSM-5, which removed OCD from the anxiety dis-
orders category and does not include anxiety as a core
symptom of OCD1. Thus, our results suggest that BTBD3
may modulate neural processes contributing to
compulsive-like behaviors, including impaired exploratory
drive and/or reduced goal-directed behavior, which are
independent of anxious-depressive phenotypes. The Btbd3
behavioral profile is thus distinct from several genetic
mouse models of OCD, which exhibit a repetitive beha-
vior, such as excessive self-grooming or self-barbering
concomitant with increased anxiety-like behaviors66,86,87.
We did not observe effects of Btbd3 genotype on
additional behavioral measures including motivation,
startle, or sensorimotor behaviors. Motivation was unal-
tered in Btbd3 HT and KO mice in the PRBP, as was
response inhibition as indicated by false alarm rate in the
Go/No-Go task (Supplementary Fig. 1b). Btbd3 HT and
KO mice also did not show differences in sensorimotor
gating (Supplementary Fig. 1f) or startle reactivity (Sup-
plementary Fig. 1g). Furthermore, no effects of Btbd3
genotype were observed on sensory or motor measures in
the olfactory dis/habituation or olfactory memory tests,
the whisker-brushing test, or the footprint test (Supple-
mentary Fig. 2a–i). Young adult Btbd3 KO mice had
modestly reduced bodyweight, which was unlikely to
confound the other tests performed (Supplementary Fig.
2j): although, we note the common genetic variation
overlap between OCD and anorexia nervosa, and the
negative genetic correlation of both with body mass
index88. Lastly, no effects of sex were found for the phe-
notypic differences identified.
Neonatal Btbd3 KD in the whole hippocampus induced
compulsive-like behavior and reduced exploration during
adulthood, mirroring the phenotype observed in con-
stitutive Btbd3 KO mice, with minor exceptions.
Although both models showed exploration deficits,
increased locomotion in the OF, and increased
compulsive-like behavior, hippocampal Btbd3 KD mice
showed decreased spatial d but unaltered wheel-running,
while constitutive Btbd3 KO mice showed the opposite
pattern. These discrepancies may reflect different com-
pensatory changes or distinct Btbd3 expression patterns.
We did not assess barbering in the Btbd3 KD cohorts due
to the large sample sizes required for these observations.
Interestingly, a pharmacological mouse model of aspects
of OCD shows a highly similar behavioral profile, in which
5-HT1B receptor stimulation induces hyperactivity, low
spatial d, reduced vertical rearing, reduced exploratory
digging, and impaired delayed alternation perfor-
mance10,11,35,89. This observation further suggests that
reduced species-typical exploratory behaviors may be
causally related to increased compulsive-like behaviors.
Importantly, neonatal Btbd3 KD in the dorsal half of the
hippocampus did not produce any of the behavioral
effects of whole hippocampal Btbd3 KD, except for nest-
building deficits. Altogether, our findings suggest that
Btbd3 KD in the whole, but not dorsal, hippocampus
induces compulsive-like behavior and reductions in
exploration.
Surprisingly, Btbd3 genotype altered dendritic mor-
phology in ACC layer II/III pyramidal neurons, but not in
the mediodorsal thalamus, or CA1 or dentate gyrus of the
hippocampus (Supplementary Fig. 3). This result was
unexpected given the important role of BTBD3 in den-
dritic morphology in the developing barrel cortex16, and
suggests that additional region-specific functions of
BTBD3, or compensatory changes in constitutive Btbd3
KO mice produced the observed phenotypes. For
instance, BTBD3 interacts with cell signaling proteins,
such as SEC24C, which is required for trafficking the
serotonin transporter to the cell membrane90,91, and
CLTC, clathrin heavy chain protein, which is integral to
synaptic transmission90,92. Only ACC layer II/III pyr-
amidal neurons had increased spine density in Btbd3 KO
mice, which might reflect alterations in the hippocampus-
to-ACC circuit, which is implicated in goal-directed
behavior93. Indeed, neonatal ventral hippocampal lesions
in rodents are thought to disrupt the development of
prefrontal circuitry94 and enhance mesolimbic dopamine
signaling95, resulting in extradimensional shifting deficits,
hyperactivity, increased apomorphine-induced stereotypy,
and reduced rearing, marble-burying, and habituation to
novelty96–99. This behavioral profile is similar to the
phenotype of Btbd3 KO and hippocampal Btbd3 KD mice,
and aligns with the minimal behavioral effects of dorsal
hippocampus-specific Btbd3 KD. While speculative, our
results suggest the possibility that loss of BTBD3 pri-
marily in the ventral hippocampus may produce the
observed phenotype through disruption of CSTC
circuitry.
To our knowledge, our results comprise the first evi-
dence for a role of Btbd3 in behavior, which is to
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modulate compulsive-like and exploratory behaviors in
mice. Our results support the possibility that the SNP
rs6131295, an eQTL for BTBD3, may be of relevance to
neuropsychiatric disorders, despite only exceeding the
genome-wide significance threshold in the trio portion of
an OCD GWAS13. Indeed, OCD patients exhibit com-
pulsive behaviors, goal-directed behavior deficits28–30, and
reduced novelty-seeking55–58. However, other neu-
ropsychiatric disorders exhibit one or more of these
phenotypes, including autism spectrum disorder100,101,
addiction4, and binge-eating disorder4, suggesting the
potential relevance of BTBD3 to other psychiatric dis-
orders. Furthermore, SNPs revealed by GWASs likely lead
to subtle changes in gene expression, in comparison to the
large reductions in Btbd3 expression studied here in mice.
Yet, risk genes for neuropsychiatric disorders identified by
GWAS have been suggested to show an increased burden
for rare variants with larger damaging effects102,103.
Our findings show that reduced Btbd3 expression
induces compulsive-like behaviors and reduced explora-
tion, phenotypes highly relevant to neuropsychiatric dis-
orders including OCD. Furthermore, hippocampal Btbd3
expression plays an essential role in the regulation of
these behaviors, but loss of BTBD3 in dorsal hippocampus
is not sufficient to induce these effects. Future work will
determine the molecular mechanisms and developmental
time window in which Btbd3 expression confers these
phenotypes. As any behavioral role of Btbd3 was pre-
viously unreported, our work highlights the importance of
investigating unknown genes identified in an unbiased
fashion104.
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